Search research articles
Contact Us
Filters
Showing results (21-30 of 172) with videos related to
Page
of 18
Sort By:
Cancer Chemotherapy and Pharmacology
|
August 6, 2017
Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition
Qiong Yang, Florian Puhm, Michael Freissmuth, et al.
The Journal of Biological Chemistry
|
May 24, 2003
Truncation of the A1 adenosine receptor reveals distinct roles of the membrane-proximal carboxyl terminus in receptor folding and G protein coupling
Halyna Pankevych, Volodymir Korkhov, Michael Freissmuth, et al.
International Journal of Molecular Sciences
|
October 31, 2019
Kinetic Models of Secondary Active Transporters
Verena Burtscher, Klaus Schicker, Michael Freissmuth, et al.
Biophysical Journal
|
August 15, 2019
An Electrophysiological Approach to Measure Changes in the Membrane Surface Potential in Real Time
Verena Burtscher, Matej Hotka, Michael Freissmuth, et al.
The International Journal of Biochemistry & Cell Biology
|
September 12, 2017
An unfolding story: Small molecules remedy misfolded monoamine transporters
Ameya Kasture, Thomas Stockner, Michael Freissmuth, et al.
Journal of Neurochemistry
|
March 17, 2015
Cooperativity between individual transporter protomers: new data fuelling old complexes
Harald H Sitte, Gerhard J Schütz, Michael Freissmuth
International Journal of Molecular Sciences
|
June 20, 2018
Big Lessons from Tiny Flies: <i>Drosophila melanogaster</i> as a Model to Explore Dysfunction of Dopaminergic and Serotonergic Neurotransmitter Systems
Ameya Sanjay Kasture, Thomas Hummel, Sonja Sucic, et al.
Molecular Pharmacology
|
December 21, 2018
Functional Selectivity and Partial Efficacy at the Monoamine Transporters: A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release
Peter S Hasenhuetl, Shreyas Bhat, Michael Freissmuth, et al.
Pharmacology & Therapeutics
|
December 14, 2020
Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits
Shreyas Bhat, Ali El-Kasaby, Michael Freissmuth, et al.
Biological Chemistry
|
January 4, 2011
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine
Thomas Steinkellner, Michael Freissmuth, Harald H Sitte, et al.
Page
of 18
Search research articles
Search
Showing results (21-30 of 172) with videos related to
Sort By:
Page
of 18
Cancer Chemotherapy and Pharmacology
|
August 6, 2017
Hyponatremia and V2 vasopressin receptor upregulation: a result of HSP90 inhibition
Qiong Yang, Florian Puhm, Michael Freissmuth, et al.
The Journal of Biological Chemistry
|
May 24, 2003
Truncation of the A1 adenosine receptor reveals distinct roles of the membrane-proximal carboxyl terminus in receptor folding and G protein coupling
Halyna Pankevych, Volodymir Korkhov, Michael Freissmuth, et al.
International Journal of Molecular Sciences
|
October 31, 2019
Kinetic Models of Secondary Active Transporters
Verena Burtscher, Klaus Schicker, Michael Freissmuth, et al.
Biophysical Journal
|
August 15, 2019
An Electrophysiological Approach to Measure Changes in the Membrane Surface Potential in Real Time
Verena Burtscher, Matej Hotka, Michael Freissmuth, et al.
The International Journal of Biochemistry & Cell Biology
|
September 12, 2017
An unfolding story: Small molecules remedy misfolded monoamine transporters
Ameya Kasture, Thomas Stockner, Michael Freissmuth, et al.
Journal of Neurochemistry
|
March 17, 2015
Cooperativity between individual transporter protomers: new data fuelling old complexes
Harald H Sitte, Gerhard J Schütz, Michael Freissmuth
International Journal of Molecular Sciences
|
June 20, 2018
Big Lessons from Tiny Flies: <i>Drosophila melanogaster</i> as a Model to Explore Dysfunction of Dopaminergic and Serotonergic Neurotransmitter Systems
Ameya Sanjay Kasture, Thomas Hummel, Sonja Sucic, et al.
Molecular Pharmacology
|
December 21, 2018
Functional Selectivity and Partial Efficacy at the Monoamine Transporters: A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release
Peter S Hasenhuetl, Shreyas Bhat, Michael Freissmuth, et al.
Pharmacology & Therapeutics
|
December 14, 2020
Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits
Shreyas Bhat, Ali El-Kasaby, Michael Freissmuth, et al.
Biological Chemistry
|
January 4, 2011
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine
Thomas Steinkellner, Michael Freissmuth, Harald H Sitte, et al.
Page
of 18